BTD rs372844636: Understanding Biotinidase Deficiency Carrier Status
The rs372844636 variant is a rare genetic change located in the BTD gene, which is responsible for producing the enzyme biotinidase. This variant is associated with biotinidase deficiency, an inherited metabolic disorder that affects the body's ability to recycle biotin.
What each genotype means
Typical BTD genotype
This genotype represents the common, non-variant sequence at this position in the BTD gene. It is not associated with biotinidase deficiency.
This is the most common genotype observed in the general population.
Carrier of biotinidase deficiency
You carry one copy of this pathogenic variant, which is associated with biotinidase deficiency. As this condition is inherited in an autosomal recessive manner, carriers are typically asymptomatic and do not require biotin therapy, but you may wish to discuss reproductive genetic screening with a healthcare provider.
This genotype is rare, occurring in less than 0.1% of the global population according to gnomAD data.
Potential biotinidase deficiency
This genotype indicates the presence of two copies of the pathogenic variant. Biotinidase deficiency is a metabolic disorder that can cause neurological and skin-related symptoms if left untreated, though it is highly responsive to biotin supplementation. Please consult with a metabolic specialist or physician to discuss clinical testing and appropriate management.
This genotype is extremely rare in the general population.
What is the rs372844636 Variant?
The rs372844636 variant is a specific change in the DNA sequence of the BTD gene, located on chromosome 3. In genetic terms, this is a missense variant, meaning it results in a single amino acid change within the protein structure. This alteration can potentially disrupt the normal function of the biotinidase enzyme. Because biotinidase is essential for recycling biotin—a vital B vitamin—any significant reduction in its activity can lead to metabolic challenges. This variant is categorized as pathogenic in clinical databases, indicating that it is recognized as a cause of biotinidase deficiency when inherited in specific patterns. Understanding such variants is a key component of modern reproductive genetic screening, as it helps identify individuals who may carry a single copy of a gene mutation without necessarily showing symptoms themselves.
The Role of the BTD Gene
The BTD gene provides the instructions for the body to create the biotinidase enzyme. This enzyme is critical for the body's metabolic processes because it releases free biotin from proteins found in food. Once released, this free biotin acts as a necessary cofactor for enzymes known as carboxylases, which are involved in breaking down fats, proteins, and carbohydrates. When the BTD gene contains pathogenic variants, the resulting enzyme may be absent or have significantly reduced activity. This leads to a condition called biotinidase deficiency. If left untreated, this deficiency can cause a range of symptoms, including skin rashes, hair loss, and neurological issues. Because the condition is inherited in an autosomal recessive pattern, an individual typically needs to inherit two copies of a pathogenic variant—one from each parent—to experience the full clinical symptoms of profound biotinidase deficiency.
Research and Clinical Evidence
Evidence regarding rs372844636 is primarily derived from clinical genetic testing and newborn screening programs. It is classified as a pathogenic variant, meaning it is known to contribute to the development of biotinidase deficiency. However, the clinical impact of any single variant can be complex. Research shows that some individuals with partial biotinidase deficiency may have one pathogenic variant combined with another, leading to reduced but not absent enzyme activity. Because the evidence strength for some rare variants can be limited, clinicians often rely on a combination of genetic testing and biochemical assays—such as measuring actual biotinidase enzyme levels in the blood—to confirm a diagnosis. It is important to note that genetic findings should always be interpreted by a qualified healthcare professional who can correlate the molecular data with clinical symptoms and family history.
Population Frequency
The rs372844636 variant is considered rare, with a population frequency of less than 0.001 across global populations according to data from gnomAD. Because it is so uncommon, it is not frequently encountered in the general population. However, carrier rates for various BTD variants can differ significantly between different racial and ethnic groups. In the context of reproductive carrier screening, identifying such rare variants is important for families who may be at risk of having a child with biotinidase deficiency. Since the condition is recessive, the risk is only present if both parents are carriers of pathogenic variants in the BTD gene. Genetic counselors use this frequency data to help individuals understand their personal risk profiles and to guide decisions regarding further diagnostic testing or family planning.
What You Can Do With This Information
If you have received information about your status regarding rs372844636, the most important step is to discuss the results with a genetic counselor or your primary healthcare provider. This information is intended for educational purposes and does not constitute a medical diagnosis. If you are a carrier, it simply means you have one copy of the variant; it does not mean you have the disorder. If you are planning a family, your partner may also consider genetic screening to determine if they are a carrier of a BTD variant. Never make medical decisions based solely on a genetic report. Always consult with a clinician who can provide context based on your full medical history, family background, and, if necessary, follow-up biochemical testing to measure enzyme activity levels.
How common is this variant?
The rs372844636 variant is rare, with a frequency of less than 0.001 across global populations in gnomAD.
Frequently asked questions
What is biotinidase deficiency?
Biotinidase deficiency is an inherited metabolic disorder where the body cannot recycle biotin. Without enough of this enzyme, the body struggles to process fats, proteins, and carbohydrates, which can lead to health issues if not treated.
Does being a carrier mean I have the disease?
No, being a carrier typically means you have one copy of a pathogenic variant and one normal copy. Carriers are usually asymptomatic and do not have the disorder, but they can pass the variant to their children.
How is biotinidase deficiency treated?
Biotinidase deficiency is generally managed through lifelong supplementation with biotin. Early diagnosis, often through newborn screening, allows for treatment to begin before symptoms appear, which is highly effective.
Should I get tested for BTD variants?
Genetic testing for BTD variants is often part of reproductive carrier screening panels. You should discuss the benefits and limitations of this testing with a genetic counselor or your doctor to see if it is appropriate for your situation.
Sources & further reading
Educational information only, last refreshed 9/17/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs372844636?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in BTD
Carrier variant indicating predisposition to pass on autosomal recessive biotinidase deficiency.
Carrier variant associated with autosomal recessive biotinidase deficiency.
This variant is linked to biotinidase deficiency, where heterozygous carriers may be identified through clinical screening.
This variant is identified as a carrier mutation for biotinidase deficiency.
This variant is a known carrier mutation for biotinidase deficiency.
This variant is associated with carrier status for biotinidase deficiency.